Update README.md
Browse files
README.md
CHANGED
|
@@ -46,29 +46,7 @@ The JPharmatron-7B is continually pre-trained using 10T tokens from Japanese and
|
|
| 46 |
|
| 47 |
<!-- Address questions around how the model is intended to be used, including the foreseeable users of the model and those affected by the model. -->
|
| 48 |
|
| 49 |
-
|
| 50 |
-
|
| 51 |
-
<!-- This section is for the model use without fine-tuning or plugging into a larger ecosystem/app. -->
|
| 52 |
-
|
| 53 |
-
[More Information Needed]
|
| 54 |
-
|
| 55 |
-
### Downstream Use [optional]
|
| 56 |
-
|
| 57 |
-
<!-- This section is for the model use when fine-tuned for a task, or when plugged into a larger ecosystem/app -->
|
| 58 |
-
|
| 59 |
-
[More Information Needed]
|
| 60 |
-
|
| 61 |
-
### Out-of-Scope Use
|
| 62 |
-
|
| 63 |
-
<!-- This section addresses misuse, malicious use, and uses that the model will not work well for. -->
|
| 64 |
-
|
| 65 |
-
[More Information Needed]
|
| 66 |
-
|
| 67 |
-
## Bias, Risks, and Limitations
|
| 68 |
-
|
| 69 |
-
<!-- This section is meant to convey both technical and sociotechnical limitations. -->
|
| 70 |
-
|
| 71 |
-
[More Information Needed]
|
| 72 |
|
| 73 |
### Recommendations
|
| 74 |
|
|
@@ -76,38 +54,6 @@ The JPharmatron-7B is continually pre-trained using 10T tokens from Japanese and
|
|
| 76 |
|
| 77 |
Users (both direct and downstream) should be made aware of the risks, biases and limitations of the model. More information needed for further recommendations.
|
| 78 |
|
| 79 |
-
## How to Get Started with the Model
|
| 80 |
-
|
| 81 |
-
Use the code below to get started with the model.
|
| 82 |
-
|
| 83 |
-
[More Information Needed]
|
| 84 |
-
|
| 85 |
-
## Training Details
|
| 86 |
-
|
| 87 |
-
### Training Data
|
| 88 |
-
|
| 89 |
-
<!-- This should link to a Dataset Card, perhaps with a short stub of information on what the training data is all about as well as documentation related to data pre-processing or additional filtering. -->
|
| 90 |
-
|
| 91 |
-
[More Information Needed]
|
| 92 |
-
|
| 93 |
-
### Training Procedure
|
| 94 |
-
|
| 95 |
-
<!-- This relates heavily to the Technical Specifications. Content here should link to that section when it is relevant to the training procedure. -->
|
| 96 |
-
|
| 97 |
-
#### Preprocessing [optional]
|
| 98 |
-
|
| 99 |
-
[More Information Needed]
|
| 100 |
-
|
| 101 |
-
|
| 102 |
-
#### Training Hyperparameters
|
| 103 |
-
|
| 104 |
-
- **Training regime:** [More Information Needed] <!--fp32, fp16 mixed precision, bf16 mixed precision, bf16 non-mixed precision, fp16 non-mixed precision, fp8 mixed precision -->
|
| 105 |
-
|
| 106 |
-
#### Speeds, Sizes, Times [optional]
|
| 107 |
-
|
| 108 |
-
<!-- This section provides information about throughput, start/end time, checkpoint size if relevant, etc. -->
|
| 109 |
-
|
| 110 |
-
[More Information Needed]
|
| 111 |
|
| 112 |
## Evaluation
|
| 113 |
|
|
@@ -125,7 +71,7 @@ We evaluated our model, JPharmatron-7B, with other general / domain-specific mod
|
|
| 125 |
|
| 126 |
Compared to Meditron3-Qwen2.5-7B and Llama3.1-Swallow-8B-Instruct-v0.3, JPharmatron-7B achieved the highest score on all of the five benchmarks.
|
| 127 |
|
| 128 |
-
|
| 129 |
|
| 130 |
## Citation [optional]
|
| 131 |
|
|
|
|
| 46 |
|
| 47 |
<!-- Address questions around how the model is intended to be used, including the foreseeable users of the model and those affected by the model. -->
|
| 48 |
|
| 49 |
+
This model is a text-only model. Applications to pharmaceutial paperworks and research use are intended.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 50 |
|
| 51 |
### Recommendations
|
| 52 |
|
|
|
|
| 54 |
|
| 55 |
Users (both direct and downstream) should be made aware of the risks, biases and limitations of the model. More information needed for further recommendations.
|
| 56 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 57 |
|
| 58 |
## Evaluation
|
| 59 |
|
|
|
|
| 71 |
|
| 72 |
Compared to Meditron3-Qwen2.5-7B and Llama3.1-Swallow-8B-Instruct-v0.3, JPharmatron-7B achieved the highest score on all of the five benchmarks.
|
| 73 |
|
| 74 |
+

|
| 75 |
|
| 76 |
## Citation [optional]
|
| 77 |
|